Drug Report History #43543
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v10-EN | Version v3-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2018-05-30 (Updated) | 2018-04-03 |
| Drug Identification Number | 02326523 | 02326523 |
| Brand name | AMOXI-CLAV | AMOXI-CLAV |
| Common or Proper name | AMOXI-CLAV | AMOXI-CLAV |
| Company Name | PRO DOC LIMITEE | PRO DOC LIMITEE |
| Ingredients | AMOXICILLIN CLAVULANIC ACID | AMOXICILLIN CLAVULANIC ACID |
| Strength(s) | 875MG 125MG | 875MG 125MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100 | 100 |
| ATC code | J01CR | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) (Updated) | Delay in shipping of the drug. |
| Anticipated start date | (Updated) | 2018-04-02 |
| Actual start date | 2018-03-27 (Updated) | |
| Estimated end date | (Updated) | Unknown |
| Actual end date | 2018-05-30 (Updated) | |
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Discontinued as of April 26, 2018 (Updated) | |
| Health Canada comments |